Literature DB >> 21886556

Gastrodia Elata Bl Attenuates Cocaine-Induced Conditioned Place Preference and Convulsion, but not Behavioral Sensitization in Mice: Importance of GABA(A) Receptors.

E-J Shin1, J-H Bach, T-T L Nguyen, B-D Jung, K-W Oh, M J Kim, C G Jang, S F Ali, S K Ko, C H Yang, H-C Kim.   

Abstract

It has been suggested that GABAergic neurotransmission can modulate cocaine dependence and seizure activity. Since Gastrodia elata Bl (GE), an oriental herb agent, has been shown to enhance GABAergic transmission, we examined whether GE affects cocaine-induced seizures, conditioned place preference (CPP), and behavioral sensitization in mice. Treatment with GE (500 or 1000 mg/kg, p.o.) significantly delayed seizure onset time and significantly shortened seizure duration induced by cocaine (90 mg/kg, i.p.). In addition, cocaine (15 mg/kg, i.p.)-induced CPP was significantly attenuated by GE in a dose-dependent manner. However, GE did not significantly alter behavioral sensitization induced by cocaine (15 mg/kg, i.p.). In order to understand whether GABAergic receptors are implicated in GE-mediated pharmacological action in response to cocaine, GABA(A) receptor antagonist bicuculline and GABA(B) receptor antagonist SCH 50911 were employed in the present study. GE-mediated attenuations on the cocaine-induced seizures and CPP were significantly reversed by bicuculline (0.25 or 0.5 mg/kg, i.p.), but not by SCH 50911 (1.5 or 3.0 mg/kg, i.p.). Therefore, our results suggest that GE attenuates cocaine-induced seizures and CPP via, at least in part, GABA(A) receptor activation.

Entities:  

Keywords:  GABAA receptors.; Gastrodia elata Bl; cocaine; conditioned place preference; seizure

Year:  2011        PMID: 21886556      PMCID: PMC3137195          DOI: 10.2174/157015911795017326

Source DB:  PubMed          Journal:  Curr Neuropharmacol        ISSN: 1570-159X            Impact factor:   7.363


INTRODUCTION

Cocaine is a widely used psychostimulant. According to the United Nations Office on Drugs and Crime (UNODC), the total number of people who used cocaine at least once in 2007 is estimated maximally 21 million [1]. It has been suggested that multiple neurotransmitter systems are involved in the cocaine addiction [2] and cocaine-elicited seizures [3], one of the consequences of cocaine intoxication. For instance, extensive findings indicated that cocaine dependence is primarily mediated by enhanced dopaminergic transmission, especially in the mesocorticolimbic pathway [4], but cocaine-induced dopaminergic neurotransmission and behavioral changes can be modulated by GABAergic [5] or glutamatergic [6] innervations to the mesocorticolimbic area. Previous studies also have shown that cocaine-induced seizures can be mediated by enhanced dopaminergic and glutamatergic transmissions [7] and reduced GABAergic transmission [8]. Gastrodia elata Blume (GE), a traditional oriental herbal agent, has long been used for epilepsy, stroke, and other neurological disorder in Asian countries, and its major components are gastrodin, p-hydroxybenzylaldehyde, p-hydroxybenzylalcohol, vanillyl alcohol, vanillin, and etc. [9]. A number of in vitro and in vivo studies have suggested therapeutic potentials of GE and its individual components against epileptic seizure/convulsion [10], cerebral ischemia [11], anxiety [12], and depression [13]. GE or its active components could exert pharmacological effects via anti-oxidation [14], anti-inflammation [15], and modulation of monoaminergic [13] and amino acid [16] neurotransmitter systems. Especially, GE has been shown to increase the extracellular GABA levels in in vivo microdialysis study, and to consequently enhance the GABAergic neurotransmission [17]. Earlier study suggested that activation of GABAA receptor is important for GE-mediated anxiolytic effect in mice [12]. Since GABA-mimetic drugs and GABAergic agonists have shown to attenuate behavioral sensitization or seizures induced by cocaine [18, 19], we examined whether GE affects cocaine-induced seizures, CPP, and behavioral sensitization in mice. In addition, we examined whether GABAergic receptors are involved in GE-mediated pharmacological action in response to cocaine.

METHODS

All animals were treated in accordance with the NIH Guide for the care and use of laboratory animals (NIH Publication No. 85-23, 1985; www.dels.nas.edu/ila). This study was performed in accordance with the Institute for Laboratory Animal Research (ILAR) guidelines for the care and use of laboratory animals. Male C57BL/6J mice (Bio Genomic Inc., Charles River Technology, Gapyung-Gun, Gyeonggi-Do, South Korea) weighing 25 ± 3 g were maintained on a 12 h:12 h light:dark cycle and fed ad libitum. Cocaine hydrochloride (Hansaem Pharmaceutical Company, Seoul, South Korea) and SCH 50911 (Tocris bioscience, Ellisville, MO, USA) were dissolved in 0.9 % sterile saline. Methanol extract of GE was obtained from Samsung Herb Medicine, Co. (Chunchon, South Korea) and suspended in 0.5 % carboxymethylcellulose. (+)-Bicuculline (Tocris bioscience, Ellisville, MO, USA) was dissolved in saline acidified to pH 3 using 0.1 N HCl. All solutions were immediately prepared before use. Experimental schedules are shown in Fig. (). CPP and behavioral sensitization were performed as described previously [20]. An automated video-tracking system (Noldus Information Technology, Wageningen, The Netherlands) was employed to record and analyze the movements of mice. Statistical analyses were performed using one-way analysis of variance (ANOVA) or Chi square test. A post-hoc Fisher’s PLSD test was followed. A P-value <0.05 was accepted as statistically significant.

RESULTS AND DISCUSSION

GE Attenuated Cocaine-Induced Seizures

All mice receiving saline plus cocaine (90 mg/kg, i.p.) showed strong seizure behaviors with a latency of 188.3 ± 22.1 seconds. Treatment with GE significantly delayed cocaine-induced seizure onset, and significantly shortened seizure duration [for both of seizure latency and seizure duration: GE (500 mg/kg) + cocaine vs. Saline + cocaine, P < 0.05; GE (1000 mg/kg) + cocaine vs. Saline + cocaine, P < 0.01] in a dose-dependent manner. In addition, GE significantly increased survival rate [GE (1000 mg/kg) + cocaine vs. Saline + cocaine, P < 0.05] after cocaine-induced seizures, however GE did not affect significantly convulsing rate (Fig. and ). Since GE has been reported to enhance GABAergic neurotransmission, we applied GABAA receptor antagonist bicuculline and GABAB receptor antagonist SCH 50911 to understand whether GABAergic receptors are involved in the anti-convulsive effect of GE against cocaine toxicity. Bicuculline (0.25 or 0.5 mg/kg, i.p.) or SCH 50911 (1.5 or 3.0 mg/kg, i.p.), at the doses we used here, did not induce any seizure behavior, or affect seizure activity. GE-mediated anticonvulsant effect was significantly reversed by bicuculline [for both of seizure latency and seizure duration: bicuculline (0.5 mg/kg) + GE (1000 mg/kg) + cocaine vs. saline + GE (1000 mg/kg) + cocaine, P < 0.01] in a dose-related manner, but not by SCH 50911, suggesting that GE attenuates cocaine-induced seizures, at least in part, via GABAA receptors activation (Fig. and ). Our results were consistent with previous report [7], which has shown that GABAA receptor-positive modulator inhibits cocaine-induced seizures. In addition, another finding [24] suggested that cocaine suppresses the hippocampal inhibitory GABAA current, and that this suppression may contribute to cocaine-induced seizures, which are in line with our results.

GE Attenuated Cocaine-Induced CPP, but not Behavioral Sensitization

Although acute treatment with GE (1000 mg/kg, p.o.) significantly decreased locomotor activity (vs. Saline, P < 0.05, data not shown), mice received GE repeatedly did not show any significant difference in basal place preference (Fig. ) or locomotor activity (Fig. ) as compared with saline-treated mice. Cocaine (15 mg/kg, i.p.)-induced CPP was significantly blocked by GE [GE (500 mg/kg) or GE (1000 mg/kg) + cocaine vs. Saline + cocaine, P < 0.01] (Fig. ), whereas GE failed to attenuate behavioral sensitization induced by cocaine (Fig. ). Similarly, Filip et al. [18, 21] showed that some GABA-mimetic agents, which increase synaptic GABA transmission, have showed different effects on cocaine-induced behavioral sensitization and self-administration, suggesting that unknown neuropharmacological mechanisms are also involved in the anti-cocaine effects of these GABA-mimetic agents. Since GE has been reported to modulate not only GABAergic system, but also other neurotransmitter systems [13, 16], it remains to be explored on this discrepancy using precise pharmacological tools/parameters. In addition, it has been demonstrated that the expression of cocaine sensitization requires GABAergic modulation, which showing decreased GABAergic responses [22] in the striatum and nucleus accumbens, while increased GABAergic responses in the medial prefrontal cortex [23]. In order to examine whether specific GABAergic receptors are involved in the GE-mediated pharmacological action in response to cocaine-induced CPP, GABAA receptor antagonist bicuculline and GABAB receptor antagonist SCH 50911 were used in the present study. Bicuculline (0.25 or 0.5 mg/kg, i.p.) or SCH 50911 (1.5 or 3.0 mg/kg, i.p.), at the doses we used, did not affect cocaine-elicited CPP. GE-mediated attenuation on cocaine-induced CPP was significantly reversed by bicuculline [bicuculline (0.25 mg/kg) or bicuculline (0.5 mg/kg) + GE (1000 mg/kg) + cocaine vs. saline + GE (1000 mg/kg) + cocaine, P < 0.05 or P < 0.01] in a dose-related manner, but not by SCH 50911, suggesting that stimulation of GABAA receptors may be essential for the pharmacological action of GE (Fig. ). Thus, our results may be in line with the previous finding, which has shown that GABAA receptor positive-modulators inhibit rewarding properties of cocaine [24]. In addition, it has been reported that intra-hippocampal injection of muscimol, a GABAA receptor agonist, inhibits context acquisition and expression of CPP paradigm after cocaine injection [25], suggesting that modulation of hippocampal GABAergic system is important for context-cocaine associations. Thus, it remains to be explored whether this area is involved in the GE-mediated attenuation of CPP induced by cocaine. Taken together, our finding suggests that treatment with GE attenuates cocaine-induced seizures and CPP via, at least in part, GABAA receptor activation.
  24 in total

Review 1.  Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement.

Authors:  S M Anderson; R C Pierce
Journal:  Pharmacol Ther       Date:  2005-02-26       Impact factor: 12.310

2.  Effects of cocaine-induced behavioural sensitization on GABA transmission within rat medial prefrontal cortex.

Authors:  Prathiba Jayaram; Jeffery D Steketee
Journal:  Eur J Neurosci       Date:  2005-04       Impact factor: 3.386

3.  A microdialysis study of effects of gastrodin on neurochemical changes in the ischemic/reperfused rat cerebral hippocampus.

Authors:  Xianghui Zeng; Yun Zhang; Shaoming Zhang; Xiaoxiang Zheng
Journal:  Biol Pharm Bull       Date:  2007-04       Impact factor: 2.233

4.  Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations.

Authors:  Y Li; X T Hu; T G Berney; A J Vartanian; C D Stine; M E Wolf; F J White
Journal:  Synapse       Date:  1999-12       Impact factor: 2.562

5.  A study of the neuroprotective effect of the phenolic glucoside gastrodin during cerebral ischemia in vivo and in vitro.

Authors:  Xianghui Zeng; Shaomin Zhang; Le Zhang; Keping Zhang; Xiaoxiang Zheng
Journal:  Planta Med       Date:  2006-11-06       Impact factor: 3.352

6.  Anti-inflammatory and anti-angiogenic activities of Gastrodia elata Blume.

Authors:  Eun-Kyoung Ahn; Hye-Jin Jeon; Eun-Ju Lim; Hyun-Joo Jung; Eun-Hee Park
Journal:  J Ethnopharmacol       Date:  2006-10-19       Impact factor: 4.360

7.  Effect of GABA agonists and GABA-A receptor modulators on cocaine- and food-maintained responding and cocaine discrimination in rats.

Authors:  Andrew C Barrett; S Stevens Negus; Nancy K Mello; S Barak Caine
Journal:  J Pharmacol Exp Ther       Date:  2005-07-20       Impact factor: 4.030

8.  Effects of repeated cocaine on medial prefrontal cortical GABAB receptor modulation of neurotransmission in the mesocorticolimbic dopamine system.

Authors:  Prathiba Jayaram; Jeffery D Steketee
Journal:  J Neurochem       Date:  2004-08       Impact factor: 5.372

9.  Anxiolytic-like effects of Gastrodia elata and its phenolic constituents in mice.

Authors:  Ji Wook Jung; Byung Hoon Yoon; Hye Rim Oh; Jae-Hyeong Ahn; Sun Yeou Kim; Sang-Yong Park; Jong Hoon Ryu
Journal:  Biol Pharm Bull       Date:  2006-02       Impact factor: 2.233

10.  Cocaine: evidence for NMDA-, beta-carboline- and dopaminergic-mediated seizures in mice.

Authors:  I Ushijima; T Kobayashi; M Suetsugi; K Watanabe; M Yamada; K Yamaguchi
Journal:  Brain Res       Date:  1998-06-29       Impact factor: 3.252

View more
  3 in total

1.  Female Japanese quail with high levels of estradiol demonstrate cocaine-induced conditioned place preference.

Authors:  Karin E Gill; Anna R Reynolds; Mark A Prendergast; Chana K Akins
Journal:  Exp Clin Psychopharmacol       Date:  2016-03-10       Impact factor: 3.157

2.  N-Methyl, N-propynyl-2-phenylethylamine (MPPE), a Selegiline Analog, Attenuates MPTP-induced Dopaminergic Toxicity with Guaranteed Behavioral Safety: Involvement of Inhibitions of Mitochondrial Oxidative Burdens and p53 Gene-elicited Pro-apoptotic Change.

Authors:  Eun-Joo Shin; Yunsung Nam; Ji Won Lee; Phuong-Khue Thi Nguyen; Ji Eun Yoo; The-Vinh Tran; Ji Hoon Jeong; Choon-Gon Jang; Young J Oh; Moussa B H Youdim; Phil Ho Lee; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Mol Neurobiol       Date:  2015-11-13       Impact factor: 5.590

Review 3.  Neuropharmacological Potential of Gastrodia elata Blume and Its Components.

Authors:  Jung-Hee Jang; Yeonghoon Son; Seong Soo Kang; Chun-Sik Bae; Jong-Choon Kim; Sung-Ho Kim; Taekyun Shin; Changjong Moon
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-12       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.